Expanding Options for Patients With Acute Myeloid Leukemia: Guidance to Optimize Current and Evolving Therapeutic Approaches

Download All
In this program, experts review the recommended guidelines for managing acute myeloid leukemia, including the latest data on emerging therapies. Download the slidesets from a live CME/CE/CPE-certified webinar and read an expert commentary.
Naval G. Daver, MD
Amir T. Fathi, MD

Downloadable Slidesets

Download these slides from a live webinar for the most recent data on selecting AML therapy for patients without predictive biomarkers or molecular alterations.

Naval G. Daver, MD Released: July 28, 2022

Download these slides from a live webinar for the most recent data on selecting AML therapy for patients with predictive biomarkers or molecular alterations.

Amir T. Fathi, MD Released: July 28, 2022

Download these slides from a live webinar where 2 experts discuss novel emerging therapies in the treatment of AML

Naval G. Daver, MD Amir T. Fathi, MD Released: July 28, 2022
Provided by the National Comprehensive Cancer Network in partnership with Clinical Care Options, LLC
NCCN Logo

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie Inc.
Genentech, a member of the Roche Group
Jazz Pharmaceuticals, Inc.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings